VINC
Vincerx Pharma, Inc. Common Stock
VINC
VINC
Delisted
VINC was delisted on the 22nd of April, 2025.
35 hedge funds and large institutions have $13M invested in Vincerx Pharma, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 17 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
35
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.1M | |
| 2 | +$1.44M | |
| 3 | +$94.5K | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
+$80.3K |
| 5 |
SRC
Sage Rhino Capital
Menlo Park,
California
|
+$29.3K |
Top Sellers
| 1 | -$1.75M | |
| 2 | -$1.05M | |
| 3 | -$947K | |
| 4 |
CC
Clearline Capital
New York
|
-$360K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$284K |